GleamWall
中文EN

VSTM Verastem, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1526119 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY25.8%
TTM EPS YoY57.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-193.7%
Net margin-178.4%
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-88.0%
ROIC (approx.)—
Asset turnover0.49x

Leverage & solvency

Liabilities / assets95.6%
Debt / equity0.00x
Current ratio1.93x
Interest coverage-141.93x

Cash quality & payout

Operating cash flow / net income0.89x
Accruals ratio-9.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$30.91M$10.00M
R&D expense$114.60M$81.33M
SG&A expense$81.15M$43.62M
Operating income-$170.13M-$114.96M
Interest expense$1.14M$4.56M
Pretax income-$209.47M-$130.45M
Income tax—$185,000
Net income-$209.47M-$130.64M
EBITDA-$170.10M-$114.93M
EPS (basic)-3.02-3.66
EPS (diluted)-3.02-3.66
Weighted avg. shares (diluted)69.31M35.71M
Balance sheet
Cash & equivalents$204.99M$89.06M
Inventory$1.83M—
Current assets$223.41M$94.96M
PP&E, net—$32,000
Intangibles$16.43M—
Total assets$246.44M$101.54M
Current liabilities$72.27M$30.97M
Long-term debt—$40.72M
Total debt—$40.72M
Total liabilities$189.25M$130.43M
Shareholders' equity$57.20M-$28.89M
Net debt—-$48.34M
Shares outstanding77.74M44.78M
Cash flow statement
Operating cash flow-$137.51M-$104.77M
Capital expenditure—$28,000
Free cash flow—-$104.80M
Investing cash flow-$9.62M$59.97M
Financing cash flow$263.31M$54.78M
Depreciation & amortization$30,000$26,000
Stock-based compensation$9.40M$7.34M

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.